Vimarsana
Biggest News Aggregation in the World

Page 3 - Bloom Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bloom Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bloom Lab Today - Breaking & Trending Today

Omicron subvariants getting better at evading antibodies - Vimarsana News

Omicron subvariants getting better at evading antibodies

Scientists have been increasingly focusing on the BA.2.75.2, BF.7 (also known as BA.5.2.1.7) and BQ.1.1 variants in recent weeks.

Source: jpost.com
Omicron sub-variant BA.2.75 not dangerous as 'hyped': Expert - Vimarsana News

Omicron sub-variant BA.2.75 not dangerous as 'hyped': Expert

The latest Omicron sub-variant BA.2.75, first detected in India in June, is not dangerous as "hyped" as it is not surging cases or death rates, according to global health experts.Data from Nextstrain, an open-source platform, showed ...

New Covid-19 Omicron sub-variant BA.2.75 in India a cause for worry? Here's all we know about it | India News - Vimarsana News

New Covid-19 Omicron sub-variant BA.2.75 in India a cause for worry? Here's all we know about it | India News

While WHO is keeping a close watch, Soumya Swaminathan, chief scientist at WHO said it's too early to dub the variant as

Source: india.com
Too early to call new BA.2.75 sub-variant more severe: Soumya Swaminathan - Vimarsana News

Too early to call new BA.2.75 sub-variant more severe: Soumya Swaminathan

It is too early to call the latest Omicron sub-variant BA.2.75, first reported from India last month, more severe, according to Soumya Swaminathan, chief scientist at the World Health Organization (WHO).Besides India, BA.2.75 has also been ...

What do we know about the latest Omicron subvariant BA.2.75? - Vimarsana News

What do we know about the latest Omicron subvariant BA.2.75?

A new Omicron subvariant circulating in India has been detected in NZ for the first time. Early evidence suggests it may be more successful in avoiding immunity than earlier variants.

Source: rnz.co.nz